The tumor microenvironment in solid tumors presents significant challenges such as physical barriers, immunosuppressive factors, and heterogeneous antigen expression. Next generation CAR T cells are being engineered with features like enhanced trafficking abilities and resistance to immunosuppressive signals to overcome these obstacles.
